on 07 Nov 2023
Last Applicant/ Owned by
43 Foundry Avenue, Suite 120
Waltham
MA
02453
Serial Number
97260868 filed on 10th Feb 2022
Registration Number
7210201 registered on 07th Nov 2023
Correspondent Address
John Paul Oleksiuk
Filing Basis
1. intent to use
Disclaimer
NO DATA
Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tiss Read More
Scientific and medical research and development services in the field of treatment of rare genetic diseases, conditions and disorders primarily related to the muscle or central nervous system
Gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biopharmaceutical preparations, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations; therapeutic biopharmaceutical products for medical and clinical gene therapy; all of the above for the treatment of genetic diseases, conditions and disorders primarily related to the muscle or central nervous system
No 97260868
No Service Mark
No 338504-20060
Yes
No
No
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
07th Nov 2023 | REGISTERED-PRINCIPAL REGISTER |
07th Nov 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
22nd Aug 2023 | PUBLISHED FOR OPPOSITION |
22nd Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
02th Aug 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
14th Jul 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
12th Jul 2023 | ASSIGNED TO LIE |
12th Jul 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
12th Jul 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
10th Mar 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |